Harvard Bioscience, a developer, manufacturer and marketer of a broad range of solutions to advance life science, entered into a credit agreement with Cerberus Business Finance serving as administrative agent and collateral agent for the lenders.
The credit facility consists of a $64 million term loan and a $25 million revolving line of credit, of which approximately $4.8 million was drawn at closing.
The facility helped support Harvard’s acquisition of Data Sciences International. Harvard’s aggregate consideration in connection with the transaction was approximately $70 million.
